The Recall Desk
Agency classClass IIOur severity:HighFDA (Devices)·Z-1265-2025·Announced 2025-03-12

MiniMed Insulin Pump May Malfunction at High Altitude During Flight

Medtronic MiniMed insulin pumps may deliver abnormal insulin doses during airplane takeoff or landing due to air pressure changes, potentially causing severe low or high blood sugar.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This FDA Class II recall involves potential for life-threatening outcomes (death, seizure, coma) from abnormal insulin delivery triggered by altitude pressure changes. However, no illnesses, injuries, or deaths have been reported in the source text. Per the rubric, risk-of-harm products with no reported harm qualify as High (Score 3) rather than Severe.

Plain-English summary

Medtronic MiniMed insulin pumps (including 770G series and earlier Paradigm, 530G, 6XX, and 7XX series) are subject to recall due to potential abnormal insulin delivery caused by changes in air pressure. This malfunction can occur during airplane takeoff or landing.

An unexpected additional insulin dose during takeoff may cause severe hypoglycemia, which can lead to altered mental status, seizures, coma, or death. An unexpected under-delivery of insulin during landing may cause severe hyperglycemia, dehydration, or diabetic ketoacidosis, which can also be life-threatening.

Approximately 106,289 units have been distributed worldwide, including across all U.S. states and territories, as well as internationally.

Patients using affected pumps should contact Medtronic MiniMed for further guidance. Any patient experiencing symptoms of severe low or high blood sugar while flying should seek immediate medical attention.

The recalled product

Product
MiniMed insulin pump, REF: 770G (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
Manufacturer
Medtronic MiniMed, Inc.
Category
Medical Device — Insulin Pump
Hazard
Affected units
106,289

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • All Lot Numbers
  • All UDI numbers

Distribution

Distributed nationwide across the United States.

The notice also names 53 states specifically:

Part of a larger recall action

This product is one of 12 recalled by Medtronic MiniMed, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 12 products in this recall →

Related recalls

Same manufacturer · Medtronic MiniMed, Inc.

See all →

Similar recalls